Please assess the completion status of the following clinical trial:

Trial Title: Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 18 years or older.~2. Both male and female~3. Within 24 hours from admission.~4. Having 25 -Hydroxyvitamin D level of 12 ng/ml or lower.~Exclusion Criteria~1. Pregnant or lactating females.~2. Do not resuscitate (DNR) status or comfort measures only~3. No consent~4. Severely impaired gastrointestinal functions (e.g, paralytic ileus, continuous nasogastric tube drainage, strict nil per oral- no medication, malabsorption syndrome, chronic diarrhea etc)~5. History of renal stones within past year~6. Past history of hypercalcemia, tuberculosis or sarcoidosis.~7. Baseline serum total calcium ≥10.6 mg/dl or ionized serum calcium ≥ 5.4 mg/dl.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cholecalciferol (Type: EXPERIMENTAL): This group of patients will receive single high dose of vitamin D (Cholecalciferol) dissolved in 45 ml of fresh milk (Nestle)
- Placebo (Type: PLACEBO_COMPARATOR): This group of patients will receive placebo - 45 ml of fresh milk (Nestle) so that the amount, color, smell, taste etc will be the same as that of experimental drug)

Based on this trial design, predict the completion outcome and termination type (if applicable).